Case Report
Copyright ©The Author(s) 2016.
World J Clinical Cases. Sep 16, 2016; 4(9): 296-301
Published online Sep 16, 2016. doi: 10.12998/wjcc.v4.i9.296
Figure 4
Figure 4 The figure depicts differential high mobility group-A1 immunostaining. A: Minimal immune-expression in initial sample (grade II); B: At first recurrence (grade II); C: Increased signal intensity of the marker in sample from second recurrence (grade II); D: HMGA1 expression highly up-regulated with progression to histopathological grade III. HMGA1: High mobility group-A1.